| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 2074-2081 |
| Number of pages | 8 |
| Journal | Annals of Oncology |
| Volume | 27 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 1 2016 |
Keywords
- Journal Article
Cite this
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. / Rosati, G.; Aprile, G.; Scartozzi, Mario; Pasini, F.; Cantore, M.; Ferrari, D.; Barni, S.; Labianca, R.; Investigators, TOSCA (Three or Six Colon Adjuvant); Nasti, Guglielmo; Iaffaioli, Rosario Vincenzo.
In: Annals of Oncology, Vol. 27, No. 11, 01.11.2016, p. 2074-2081.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
AU - Rosati, G.
AU - Aprile, G.
AU - Scartozzi, Mario
AU - Pasini, F.
AU - Cantore, M.
AU - Ferrari, D.
AU - Barni, S.
AU - Labianca, R.
AU - Investigators, TOSCA (Three or Six Colon Adjuvant)
AU - Nasti, Guglielmo
AU - Iaffaioli, Rosario Vincenzo
N1 - © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
PY - 2016/11/1
Y1 - 2016/11/1
KW - Journal Article
U2 - 10.1093/annonc/mdw404
DO - 10.1093/annonc/mdw404
M3 - Articolo
VL - 27
SP - 2074
EP - 2081
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 11
ER -